163 related articles for article (PubMed ID: 31883956)
1. Growth differentiation factor 15 as a useful biomarker of heart failure in young patients with unrepaired congenital heart disease of left to right shunt.
Kagiyama Y; Yatsuga S; Kinoshita M; Koteda Y; Kishimoto S; Koga Y; Suda K
J Cardiol; 2020 Jun; 75(6):697-701. PubMed ID: 31883956
[TBL] [Abstract][Full Text] [Related]
2. [Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure].
Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):95-8. PubMed ID: 23428120
[TBL] [Abstract][Full Text] [Related]
3. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
[TBL] [Abstract][Full Text] [Related]
5. Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.
Sharma A; Stevens SR; Lucas J; Fiuzat M; Adams KF; Whellan DJ; Donahue MP; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM; Felker GM
JACC Heart Fail; 2017 Oct; 5(10):724-734. PubMed ID: 28958347
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of growth differentiation factor-15 and β2-microglobulin in children with congenital heart disease combined with chronic heart failure and its relationship with cardiac function.
Zhou XJ; Zhang X; Zhang J; Zhou L; Zhou TT; Zhang JW
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8096-8103. PubMed ID: 32767337
[TBL] [Abstract][Full Text] [Related]
7. Correlation of plasma B-type natriuretic peptide with shunt volume in children with congenital heart disease involving left-to-right shunt.
Kavga M; Varlamis G; Giannopoulos A; Papadopoulou-Legbelou K; Varlamis S; Bompotis G; Koulourida V; Nikolaides N
Hellenic J Cardiol; 2013; 54(3):192-8. PubMed ID: 23685656
[TBL] [Abstract][Full Text] [Related]
8. Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure.
Li J; Cui Y; Huang A; Li Q; Jia W; Liu K; Qi X
Med Sci Monit; 2018 Jul; 24():4992-4999. PubMed ID: 30019695
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
[TBL] [Abstract][Full Text] [Related]
10. The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease.
Benes J; Kotrc M; Wohlfahrt P; Conrad MJ; Franekova J; Jabor A; Lupinek P; Kautzner J; Melenovsky V; Jarolim P
Can J Cardiol; 2019 Apr; 35(4):462-470. PubMed ID: 30935637
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
Raedle-Hurst TM; Koenigstein K; Gruenhage F; Raedle J; Herrmann E; Abdul-Khaliq H
Am Heart J; 2010 Dec; 160(6):1105-12. PubMed ID: 21146665
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
[TBL] [Abstract][Full Text] [Related]
14. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
15. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-D plasma levels in fluid overload and cardiac function evaluation of elderly patients with cardiovascular disease.
Li J; Li XL; Liu FH; Yu YF; Du Y
Medicine (Baltimore); 2023 Nov; 102(46):e36062. PubMed ID: 37986336
[TBL] [Abstract][Full Text] [Related]
17. Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease.
Eindhoven JA; van den Bosch AE; Oemrawsingh RM; Baggen VJ; Kardys I; Cuypers JA; Witsenburg M; van Schaik RH; Roos-Hesselink JW; Boersma E
Int J Cardiol; 2016 Jan; 202():246-51. PubMed ID: 26402453
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
Bouabdallaoui N; Claggett B; Zile MR; McMurray JJV; O'Meara E; Packer M; Prescott MF; Swedberg K; Solomon SD; Rouleau JL;
Eur J Heart Fail; 2018 Dec; 20(12):1701-1709. PubMed ID: 30204280
[TBL] [Abstract][Full Text] [Related]
19. [Changes in serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3, and their significance in children with left-to-right shunt congenital heart disease associated with heart failure].
Peng J; Fu J; Deng SZ; Wang RG; Liu L; Sun DM; Xia K
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):277-80. PubMed ID: 23607950
[TBL] [Abstract][Full Text] [Related]
20. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
